Vitrum Osteomag and calcium carbonate efficacy comparative assessment in patients with rheumatoid arthritis receiving glucocorticoids
Objective, To study efficacy and safety of Vitrum Osteomag (VO) in prophylaxis of osteoporosis in pts with rheumatoid arthritis (RA) during 12 months. Material and Methods. 50 female with osteopenia confirmed with densitometry were included aged 50 to 70 years in the menopause for more than 2 years...
Saved in:
| Main Authors: | I S Dydykina, Y. V. Muravyov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2004-02-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/1237 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience with denosumab therapy for osteoporosis in rheumatoid arthritis patients receiving glucocorticoids
by: I. S. Dydykina, et al.
Published: (2018-06-01) -
CHANGES OF CLINICAL AND RADIOGRAPHIC PARAMETERS DURING DENOSUMAB THERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING GLUCOCORTICOIDS: PRELIMINARY RESULTS
by: P. S. Dydykina, et al.
Published: (2015-09-01) -
Revisiting the question of the safety of glucocorticoids use of in the treatment of rheumatoid arthritis
by: E. A. Aronova, et al.
Published: (2023-07-01) -
Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
by: O. V. Dobrovolskaya, et al.
Published: (2019-05-01) -
Evaluation of the modified combined glucocorticoid toxicity index in rheumatoid arthritis: Preliminary data
by: V. V. Lebedeva, et al.
Published: (2020-02-01)